A new therapy for tuberculosis can cut treatment from six months to four.
Tuberculosis experts at Johns Hopkins and in Brazil found evidence that substituting the antibiotic moxifloxacin for one of the drugs used to treat the highly contagious lung disease could dramatically improve treatment.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.